VSTM
Verastem, Inc.
stockNASDAQ
At CloseOct 30, 2026 4:49:30 PM EDT
9.56USD-1.035%(-0.10)2,411,811
Pre-marketOct 30, 2026 10:29:29 AM EDT
9.59USD-0.725%(-0.07)
VSTM News
Novocure partners with Verastem on pancreatic cancer trial · 
Investing.com
Wainwright reiterates Verastem stock rating on China trial data · Investing.com
Verastem’s KRAS inhibitor posts wins in mPDAC, mCRC and NSCLC · 
Clinical Trials Arena
Verastem cancer drug shows early promise in small study · 
BioPharma Dive
Why is Verastem stock surging today? · Investing.com
At a glance: stocks gapping up premarket · 
Seeking Alpha
Verastem Oncology prices $250 million stock offering · Investing.com
Verastem names Michael Bailey as CEO effective January 2027 · Investing.com
Catalyst watch: Big bank earnings, CPI, and the Paris Auto Show · Seeking Alpha
Verastem stock maintained at Buy by BTIG ahead of data readout · Investing.com
Verastem shares get Buy rating reiterated by H.C. Wainwright · Investing.com
Verastem presents new data on ovarian cancer drug combination · Investing.com